{"id":"https://openalex.org/W2197145779","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","title":"A phase 2 study of a novel transforming growth factor-beta (TGF-\u03b21) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).","display_name":"A phase 2 study of a novel transforming growth factor-beta (TGF-\u03b21) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-20","ids":{"openalex":"https://openalex.org/W2197145779","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","mag":"2197145779"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.3_suppl.lba173","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2197145779"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002864173","display_name":"Sandrine J. Faivre","orcid":"https://orcid.org/0000-0002-1590-485X","observed_orcids":["https://orcid.org/0000-0002-1590-485X"]},"institutions":[{"id":"https://openalex.org/I2799502834","display_name":"H\u00f4pital Beaujon","ror":"https://ror.org/03jyzk483","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2799502834","https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandrine J. Faivre","raw_affiliation_strings":["H\u00f4pital Beaujon, Clichy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Beaujon, Clichy, France","institution_ids":["https://openalex.org/I2799502834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100766578","display_name":"Armando Santoro","orcid":"https://orcid.org/0000-0003-1709-9492","observed_orcids":["https://orcid.org/0000-0003-1709-9492"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Armando Santoro","raw_affiliation_strings":["Istituto Clinico Humanitas, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Clinico Humanitas, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019481117","display_name":"Robin Kate Kelley","orcid":"https://orcid.org/0000-0002-1984-2430","observed_orcids":["https://orcid.org/0000-0002-1984-2430"]},"institutions":[{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robin Kate Kelley","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA","institution_ids":["https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006848714","display_name":"Philippe Merle","orcid":"https://orcid.org/0000-0002-8230-394X","observed_orcids":["https://orcid.org/0000-0002-8230-394X"]},"institutions":[{"id":"https://openalex.org/I4210089315","display_name":"H\u00f4pital de la Croix-Rousse","ror":"https://ror.org/006evg656","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210089315","https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philippe Merle","raw_affiliation_strings":["Hopital De La Croix Rousse, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hopital De La Croix Rousse, Lyon, France","institution_ids":["https://openalex.org/I4210089315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110599195","display_name":"Ed J. Gane","orcid":"https://orcid.org/0000-0003-4086-7955","observed_orcids":["https://orcid.org/0000-0003-4086-7955"]},"institutions":[{"id":"https://openalex.org/I2801418622","display_name":"Auckland City Hospital","ror":"https://ror.org/05e8jge82","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2801418622","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ed Gane","raw_affiliation_strings":["Auckland City Hospital, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auckland City Hospital, Auckland, New Zealand","institution_ids":["https://openalex.org/I2801418622"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114777958","display_name":"Jean\u2010Yves Douillard","orcid":"https://orcid.org/0000-0002-6540-7333","observed_orcids":["https://orcid.org/0000-0002-6540-7333"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Yves Douillard","raw_affiliation_strings":["Centre Ren\u00e9 Gauducheau, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Ren\u00e9 Gauducheau, Nantes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110666041","display_name":"Dirk Waldschmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dirk Waldschmidt","raw_affiliation_strings":["Universit\u00e4tsklinikum K\u00f6ln, K\u00f6ln, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum K\u00f6ln, K\u00f6ln, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036972230","display_name":"Mary F. Mulcahy","orcid":"https://orcid.org/0000-0002-6103-0989","observed_orcids":["https://orcid.org/0000-0002-6103-0989"]},"institutions":[{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary Frances Mulcahy","raw_affiliation_strings":["Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015037000","display_name":"Charlotte E. Costentin","orcid":"https://orcid.org/0000-0001-6115-8512","observed_orcids":["https://orcid.org/0000-0001-6115-8512"]},"institutions":[{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlotte Costentin","raw_affiliation_strings":["Hospital Henri Mendor, Creteil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Henri Mendor, Creteil, France","institution_ids":["https://openalex.org/I4210130325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045203407","display_name":"Beatriz M\u00ednguez","orcid":"https://orcid.org/0000-0002-7276-9666","observed_orcids":["https://orcid.org/0000-0002-7276-9666"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beatriz Minguez","raw_affiliation_strings":["Liver Unit, Medical Oncology, Vall d'Hebron Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Unit, Medical Oncology, Vall d'Hebron Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010673149","display_name":"Pasqua Papappicco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pasqua Papappicco","raw_affiliation_strings":["Internal Medicine, Immunology, Infectious Diseases, University of Bari Medical School, Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Immunology, Infectious Diseases, University of Bari Medical School, Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020397401","display_name":"Ivelina Gueorguieva","orcid":"https://orcid.org/0000-0001-5864-8924","observed_orcids":["https://orcid.org/0000-0001-5864-8924"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ivelina Gueorguieva","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064692327","display_name":"Ann Cleverly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ann Cleverly","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007350826","display_name":"Durisala Desaiah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Durisala Desaiah","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033549340","display_name":"Michael Lahn","orcid":"https://orcid.org/0000-0002-1377-7308","observed_orcids":["https://orcid.org/0000-0002-1377-7308"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael M. Lahn","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066930632","display_name":"Sophie Ameryckx","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie Ameryckx","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006585898","display_name":"Karim Adnane Benhadji","orcid":"https://orcid.org/0000-0001-9883-6970","observed_orcids":["https://orcid.org/0000-0001-9883-6970"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karim A. Benhadji","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013952219","display_name":"\u00c9ric Raymond","orcid":"https://orcid.org/0000-0001-5491-2708","observed_orcids":["https://orcid.org/0000-0001-5491-2708"]},"institutions":[{"id":"https://openalex.org/I2799502834","display_name":"H\u00f4pital Beaujon","ror":"https://ror.org/03jyzk483","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2799502834","https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Raymond","raw_affiliation_strings":["H\u00f4pital Beaujon, Clichy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Beaujon, Clichy, France","institution_ids":["https://openalex.org/I2799502834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075457339","display_name":"Gianluigi Giannelli","orcid":"https://orcid.org/0000-0002-5140-8060","observed_orcids":["https://orcid.org/0000-0002-5140-8060"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gianluigi Giannelli","raw_affiliation_strings":["Internal Medicine, Immunology, Infectious Diseases, University of Bari Medical School, Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Immunology, Infectious Diseases, University of Bari Medical School, Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"3_suppl","first_page":"LBA173","last_page":"LBA173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ly2157299","display_name":"LY2157299","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.7390000224113464},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":0.9729999899864197},{"id":"https://openalex.org/keywords/sorafenib-refractory-disease","display_name":"sorafenib-refractory disease","score":0.8149999976158142},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7350000143051147},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.859000027179718},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.6729999780654907},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.335999995470047},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8299999833106995},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5429999828338623},{"id":"https://openalex.org/keywords/alcoholic-liver-disease","display_name":"alcoholic liver disease","score":0.7039999961853027},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9377973675727844},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7331116199493408},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6777508854866028},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6632078886032104},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6384701728820801},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5370160341262817},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5015807151794434},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4971306622028351},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4512731432914734},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.37846875190734863},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3253968358039856},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.23188471794128418},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.3_suppl.lba173","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.lba173","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2597282070","https://openalex.org/W1986034588","https://openalex.org/W7042425737","https://openalex.org/W2088944779","https://openalex.org/W2000295132","https://openalex.org/W2064494174","https://openalex.org/W2262245597","https://openalex.org/W2751641648","https://openalex.org/W2937730750","https://openalex.org/W3012458104"],"abstract_inverted_index":{"LBA173":[0],"Background:":[1],"TGF-\u03b2":[2,114],"signaling":[3],"is":[4,354],"associated":[5],"with":[6,33,37,41],"HCC":[7,31,43],"progression":[8],"in":[9,30,198,219,253,278,343,350],"moderate":[10,311],"to":[11,52,92,223,290],"poorly":[12],"differentiated":[13],"tumors":[14],"overexpressing":[15],"alpha-fetoprotein":[16],"(AFP)":[17],"levels.":[18],"We":[19],"report":[20],"here":[21],"the":[22,199,220,259,319,323,330,334],"safety,":[23],"antitumor":[24],"activity,":[25],"and":[26,69,109,115,136,241,303,347],"overall":[27,200,348],"survival":[28,349],"(OS)":[29],"patients":[32,147,179,286,353],"elevated":[34],"AFP":[35,59,120,186,248,268,280,351],"treated":[36],"LY.":[38,103],"Methods:":[39],"Patients":[40,89],"advanced":[42,55],"who":[44],"progressed":[45],"on":[46,258,318],"sorafenib":[47],"(SF)":[48],"or":[49,98],"are":[50,143],"ineligible":[51],"receive":[53],"SF,":[54],"Child-Pugh":[56,164],"A/B7":[57],"HCC,":[58],"\u22651.5x":[60],"ULN,":[61],"ECOG":[62],"PS":[63],"\u22641,":[64],"measurable":[65],"disease":[66],"(RECIST":[67],"1.1),":[68],"\u22641":[70],"prior":[71,182],"systemic":[72],"regimen":[73],"were":[74,90,106,122,148,155],"eligible.":[75],"LY":[76],"was":[77,191,210,217,236,243,264,272,338],"administered":[78],"as":[79,124],"intermittent":[80],"dosing":[81],"of":[82,178,250,255,329],"14":[83],"days":[84],"on/off":[85],"(28":[86],"days=1":[87],"cycle).":[88],"randomized":[91],"either":[93],"160":[94],"mg/day":[95,100,336],"(Arm":[96,101,150,156,202],"A)":[97],"300":[99,335],"B)":[102],"Primary":[104],"endpoints":[105,130],"time-to-progression":[107],"(TTP)":[108],"biomarker":[110,326],"changes":[111],"(serum":[112],"AFP,":[113],"E-cadherin)":[116],"for":[117,325,340],"each":[118],"dose.":[119],"responders":[121,281],"defined":[123],">20%":[125,251],"decline":[126,249],"from":[127,141],"baseline.":[128],"Secondary":[129],"included":[131],"toxicity":[132,321],"(CTCAE,":[133],"V":[134],"4.0)":[135],"pharmacokinetics":[137],"(PK).":[138],"Available":[139],"data":[140],"interims":[142],"presented.":[144],"Results:":[145],"109":[146],"enrolled":[149],"A=37;":[151],"B=72).":[152],"Baseline":[153],"characteristics":[154],"A/B):":[157],"median":[158,262,270],"age":[159],"61/63":[160],"years;":[161],"PS=0,":[162],"60%/53%;":[163],"A":[165],"97%/88%;":[166],"etiology:":[167],"hepatitis":[168,171],"C":[169],"30%/38%,":[170],"B":[172],"27%/24%,":[173],"alcohol":[174],"24%/25%.":[175],"Overall,":[176],"78%/83%":[177],"had":[180,185],"received":[181],"SF;":[183],"57%/53%":[184],">400":[187],"ng/mL.":[188],"Median":[189,232],"TTP":[190,209,216,346],"12.0":[192],"weeks":[193,212,274,277],"(90%":[194,213],"CI:":[195,214],"6.6,":[196],"12.6)":[197],"population":[201],"A/B,":[203],"12.1/10.0":[204],"weeks).":[205,231],"In":[206,267],"SF-naive":[207],"patients,":[208],"18.3":[211],"6.6-42.4).":[215],"higher":[218],"non-alcohol":[221],"compared":[222],"alcohol-only":[224],"etiology":[225],"group":[226],"(median":[227],"12.1":[228],"vs.":[229],"6.1":[230,244],"baseline":[233],"serum":[234],"TGF-\u03b21":[235],"3.4":[237],"ng/mL":[238],"(range:":[239,246],"1.4-3.7)":[240],"E-cadherin":[242],"mg/mL":[245],"1.9-17.3).":[247],"occurred":[252],"24%":[254],"patients.":[256],"Based":[257,317],"latest":[260],"interim,":[261],"OS":[263,271],"36":[265],"weeks.":[266],"responders,":[269],"93.1":[273],"vs":[275],"29.6":[276],"non":[279],"(Log":[282],"Rank":[283],"p=0.0006).":[284],"Four":[285],"discontinued":[287],"treatment":[288],"due":[289],"AEs.":[291],"Most":[292],"common":[293],"grade":[294],"3/4":[295],"related":[296],"AEs":[297],"were:":[298],"neutropenia":[299],"(n=3),":[300],"fatigue":[301],"(n=2),":[302],"anemia":[304],"(n=3).":[305],"Preliminary":[306],"PK":[307],"analysis":[308,328],"(n=51)":[309],"demonstrated":[310],"interpatient":[312],"exposure":[313],"variability":[314],"(42%).":[315],"Conclusions:":[316],"manageable":[320],"profile,":[322],"evidence":[324],"responses,":[327],"aggregate":[331],"PK/PD":[332],"data,":[333],"dose":[337],"chosen":[339],"future":[341],"studies":[342],"HCC.":[344],"Both":[345],"responding":[352],"promising.":[355]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2197145779","counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
